DCSIMG
21 Other non-current liabilities - Annual Report 2015 - DSM

21 Other non-current liabilities

Table 1

 
2015
2014
     
Investment grants
40
42
Deferred items
11
29
Other non-current liabilities
177
10
     
Total
228
81

The increase in the non-current liabilities relates to the drawing rights agreements with ChemicaInvest for caprolactam supply for a period of 15 years. See also note 8 'Intangible assets'.